Dow Up 0.15% Nasdaq Up 0.21%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.34 Down 0.01(0.74%) 4:00PM EDT
- Nasdaq Real Time Price
Prev Close:1.35
Open:1.34
Bid:1.34 x 28600
Ask:1.35 x 23500
1y Target Est:4.50
Beta:3.76
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.32 - 1.38
52wk Range:1.10 - 2.14
Volume:463,293
Avg Vol (3m):1,740,870
Market Cap:352.26M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXDown 0.74%352.26M
GSKDown 0.42%113.13B
MRKDown 0.18%172.73B
RHHBYDown 0.24%254.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback